I have 20+ years of experience in R&D and leading/executive management positions in Swedish and Danish biotech and pharma companies. I have a broad experience in early to late stage drug development. • Prepared and completed an IPO together with the management team of Ascelia Pharma AB. Co-builder of the company.• Co-developed and implemented new business strategies, incl. acquisition of a biotech company, in- and out-licensing of projects.• Built and led highly performing teams in both R&D line and project functions for 10+ years. incl. alliance management and transition of projects from research to development.• Clinical development experience with preparation and conduct via CROs of 3 phase III, 4 phase II, 5 phase I clinical development projects in different indications. Experienced in outsourcing of clinical operations and vendor management. Identified and managed Key Opinion Leaders. • Regulatory strategies incl. expedited procedures for clinical development projects established. Clinical protocols and IND package discussed in Scientific Advice meetings with the FDA and EMA. Orphan Drug Designation obtained in US and EU for different projects. • 7 years of CMC experience incl. identification of external supplier of IMP, contract negotiations, tech transfer, upscaling, vendor management and life cycle management. Secured IMP for a phase 3 program. Co-inventor a new formulation patent application.Areas of experience/interest: Early to late stage drug development of pharmaceuticals, building and maturation of companies, IPO, R&D strategy and management, outsourcing, regulatory affairs, clinical drug development, orphan drug development, in- and out-licensing, acquisitions, alliance management, drug discovery, IPR, diagnostics, therapeutics, contrast agents, medical imaging, oncology, autoimmunity, inflammation, medicinal chemistry, structural medicinal chemistry.